News
With just two wins from eight matches, SRH now sit second-last on the IPL 2025 points table. Naturally, the conversation drifted toward their playoff chances. But when Mishra was asked directly ...
MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage non ...
MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial.
The 3-year overall survival rates for each group were 83.1% for the MSD-ASCT group, 85.7% for the auto-HSCT group, and 70.4% for the chemotherapy group. For patients with acute myeloid leukemia ...
Attendees can ask questions, share experiences, and get updates on what's causing the odors.
Opencore files to run MacOS Catalina to Sequoia on AMD Ryzen 5 3600 CPU, AMD Radeon RX570 4gb GPU and Gigabyte B450 Aorus Elite motherboard using the BsxOc1 theme.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results